Artal Group’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-350,000
Closed -$47.9M 141
2022
Q3
$47.9M Sell
350,000
-175,000
-33% -$28.5M 2.04% 16
2022
Q2
$92.9M Sell
525,000
-125,000
-19% -$18M 4.96% 5
2022
Q1
$93.6M Buy
650,000
+150,000
+30% +$20.3M 3.92% 7
2021
Q4
$77.3M Buy
500,000
+125,000
+33% +$20.9M 2.1% 10
2021
Q3
$63.7M Buy
+375,000
New +$58.4M 1.42% 19
2017
Q3
Sell
-75,000
Closed -$3.84M 121
2017
Q2
$3.88M Hold
75,000
0.07% 75
2017
Q1
$4.71M Buy
+75,000
New +$4.68M 0.1% 61

Other funds holding SGEN

Artal Group's SGEN Position: Q4 2022 in Review

Artal Group sold out of Seagen Inc. Common Stock (SGEN) in Q4 2022, closing a stake of 350,000 shares — an estimated $47.9M sold.

Artal Group first reported a position in SGEN in Q1 2017 and held it in 7 quarters. The position peaked at $93.6M in Q1 2022. 538 funds tracked by Wall St. Rank hold SGEN as of Q4 2022.

  • Artal Group reported no remaining Seagen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Artal Group sold 350,000 Seagen Inc. Common Stock shares in Q4 2022, an estimated $47.9M.
  • Artal Group first reported a position in Seagen Inc. Common Stock in Q1 2017 and held it in 7 quarters.
  • Artal Group's Seagen Inc. Common Stock position peaked at $93.6M in Q1 2022.
  • 538 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2022.

Based on Artal Group's 13F filing for Q4 2022, filed 13 Feb 2023.